在全外显子组测序和全基因组测序中，谁占主导地位？是患者还是偶然发现的结果？ - Suppr

Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?

作者信息

Rosenblatt David S

机构信息

Department of Human Genetics, McGill University, Montreal General Hospital, 1650 Cedar Avenue, Room L3-319, Montreal, Quebec, Canada.

出版信息

Mol Genet Metab. 2013 Sep-Oct;110(1-2):1-2. doi: 10.1016/j.ymgme.2013.06.001. Epub 2013 Jun 7.

DOI:10.1016/j.ymgme.2013.06.001

PMID:23809103

Abstract

摘要

相似文献

Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?在全外显子组测序和全基因组测序中，谁占主导地位？是患者还是偶然发现的结果？

Mol Genet Metab. 2013 Sep-Oct;110(1-2):1-2. doi: 10.1016/j.ymgme.2013.06.001. Epub 2013 Jun 7.

Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.用于检测遗传性疾病中胚系变异的临床全外显子组和全基因组测序的开发与验证

Arch Pathol Lab Med. 2017 Jun;141(6):798-805. doi: 10.5858/arpa.2016-0622-RA. Epub 2017 Mar 31.

Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.存档的新生儿干血斑样本可用于准确的全基因组和外显子靶向下一代测序。

Mol Genet Metab. 2013 Sep-Oct;110(1-2):65-72. doi: 10.1016/j.ymgme.2013.06.004. Epub 2013 Jun 13.

Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling.全基因组和全外显子组测序在遗传性癌症中的应用：对遗传检测和咨询的影响。

Cancer J. 2012 Jul-Aug;18(4):287-92. doi: 10.1097/PPO.0b013e318262467e.

On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.关于美国医学遗传学与基因组学学会（ACMG）对临床外显子组和基因组测序中偶然发现报告的建议的合理性

J Law Med Ethics. 2015 Spring;43(1):134-42. doi: 10.1111/jlme.12201.

Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues.揭示全基因组测序和全外显子组测序在研究及临床调查中的结果：一些伦理问题。

J Med Ethics. 2015 Apr;41(4):317-21. doi: 10.1136/medethics-2013-101996. Epub 2014 Jul 18.

Exome versus transcriptome sequencing in identifying coding region variants.外显子组测序与转录组测序在鉴定编码区变异中的比较。

Expert Rev Mol Diagn. 2012 Apr;12(3):241-51. doi: 10.1586/erm.12.10.

[Concepts for the return of secondary genetic findings in medical diagnostics and research].[医学诊断与研究中次要基因发现结果反馈的相关概念]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):166-73. doi: 10.1007/s00103-014-2096-z.

Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.从基因组和外显子组测序数据中发现的具有医学意义的偶然发现的频率和处理方法：系统评价。

Physiol Genomics. 2021 Sep 1;53(9):373-384. doi: 10.1152/physiolgenomics.00025.2021. Epub 2021 Jul 12.

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单：一项政策声明

Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.

引用本文的文献

Ethical Issues in Contemporary Clinical Genetics.当代临床遗传学中的伦理问题。

Mayo Clin Proc Innov Qual Outcomes. 2018 May 8;2(2):81-90. doi: 10.1016/j.mayocpiqo.2018.03.005. eCollection 2018 Jun.

[Clinical feature and ATP8B1 mutation analysis of a patient with progressive familial intrahepatic cholestasis type I].[Ⅰ型进行性家族性肝内胆汁淤积症1例患者的临床特征及ATP8B1基因突变分析]

Zhongguo Dang Dai Er Ke Za Zhi. 2016 Aug;18(8):751-6. doi: 10.7499/j.issn.1008-8830.2016.08.016.

Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study.

Hered Cancer Clin Pract. 2016 Jun 1;14:12. doi: 10.1186/s13053-016-0052-7. eCollection 2016.

Perspectives on genetic and genomic technologies in an academic medical center: the duke experience.学术医疗中心的遗传与基因组技术展望：杜克大学的经验

J Pers Med. 2015 Apr 3;5(2):67-82. doi: 10.3390/jpm5020067.

A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk.一种评估个人基因组检测对常见疾病风险的情感影响及情绪暗示的新方法。

Public Health Genomics. 2015;18(2):104-12. doi: 10.1159/000370101. Epub 2015 Jan 21.

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.返回下一代基因组测序偶然发现结果的成本效益

Genet Med. 2015 Jul;17(7):587-95. doi: 10.1038/gim.2014.156. Epub 2014 Nov 13.

Utility of next generation sequencing in clinical primary immunodeficiencies.下一代测序在临床原发性免疫缺陷中的应用。

Curr Allergy Asthma Rep. 2014 Oct;14(10):468. doi: 10.1007/s11882-014-0468-y.

Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.临床肿瘤测序：美国医学遗传学与基因组学学会关于报告偶发发现的建议的意外牺牲品。

J Clin Oncol. 2014 Jul 20;32(21):2203-5. doi: 10.1200/JCO.2013.54.8917. Epub 2014 Jun 23.

Lysosomal diseases: diagnostic update.溶酶体疾病：诊断进展

J Inherit Metab Dis. 2014 Jul;37(4):599-608. doi: 10.1007/s10545-014-9710-y. Epub 2014 Apr 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献